Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.
about
Educational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillationEvidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesReversal of oral anticoagulationUnfractionated heparin dose requirements targeting intermediate intensity antifactor Xa concentration during pregnancy.Fibrate/Statin initiation in warfarin users and gastrointestinal bleeding riskUse of Telemedicine to Enhance Pharmacist Services in the Nursing Facility.Warfarin therapy: in need of improvement after all these years.Quality of vitamin K antagonist control and outcomes in atrial fibrillation patients: a meta-analysis and meta-regression.Improving outpatient warfarin use for hospitalized patients with atrial fibrillationOral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Pharmacists' contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers.Inpatient Oral Anticoagulation Management by Clinical Pharmacists: Safety and Cost effectiveness.Stroke prevention: age alone does not rule out warfarin.Patients' and physicians' satisfaction with a pharmacist managed anticoagulation program in a family medicine clinic.A systematic review on comparing 2 common models for management of warfarin therapy; pharmacist-led service versus usual medical care.Outpatient use of low molecular weight heparin monotherapy for first-line treatment of venous thromboembolism in advanced cancer.A strategy to develop advanced pharmacy practice experiences.Can We Predict Individual Combined Benefit and Harm of Therapy? Warfarin Therapy for Atrial Fibrillation as a Test Case.Comparing the effectiveness of pharmacist-managed warfarin anticoagulation with other models: a systematic review and meta-analysis.Monitoring of international normalized ratios: comparison of community nurses with family physicians.An Education Program for Patient Self-Management of WarfarinPrediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol.The potential role of clinical pharmacy services in patients with cardiovascular diseasesEducational and behavioural interventions for anticoagulant therapy in patients with atrial fibrillation.A Cluster-Randomized Trial of a Centralized Clinical Pharmacy Cardiovascular Risk Service to Improve Guideline Adherence.Randomized trial to improve prescribing safety during pregnancyFactors affecting the quality of anticoagulation with warfarin: experience of one cardiac centreThe impact of pharmacist-managed oral anticoagulation therapy in older veterans.Predictors of warfarin non-adherence in younger adults after valve replacement surgery in the South Pacific.Quality of anticoagulation care in patients discharged from a pharmacist-managed anticoagulation clinic after stabilization of warfarin therapy.An elective course on landmark trials to improve pharmacy students' literature evaluation and therapeutic application skills.Limited English proficient patients and time spent in therapeutic range in a warfarin anticoagulation clinic.Telephone-based anticoagulation management in the homebound setting: a retrospective observational study.Evaluation of a pharmacist-managed telephone lipid clinic at a Veterans Affairs Medical Center.A pre- post-evaluation of implementing an inpatient warfarin monitoring and education programPenny-wise, pound-foolish? Highmark Medicare Services' proposal for anticoagulation clinic reimbursement.Effectiveness of pharmacist-participated warfarin therapy management: a systematic review and meta-analysis.Contemporary management of transient ischemic attack: role of the pharmacist.Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.The use of letter communication for patients enrolled in a pharmacist managed anticoagulation clinic.
P2860
Q24202280-C0BD5860-EA73-4602-BE7B-627CF46E5EDFQ24632951-6916982C-5308-4254-B235-CC2DB96D7553Q26827835-18BF0A86-B62E-4895-A5AE-7C9A5AF3FF5FQ33388912-07E2A76E-65F6-4D1A-821E-CAF01941BC1BQ33617751-C20CC236-ED36-4A61-BA50-06903B074582Q33754587-8CBB6423-B49D-4D15-A015-0B850D0ED5C8Q33793086-EBFB99A6-4F6A-45A7-8692-93BAD46662E8Q33891646-74A5C873-F54F-47B2-96BD-13682F4C62D9Q34100740-C73348E5-1610-4B5F-AFC2-9FC989836335Q34252907-4FDC1202-55B1-46CB-B015-2822BE7DCA79Q34680652-AA165E6D-142A-4ABC-9313-B22E0144C199Q35119855-A84CC261-E77A-4B11-9B5B-EB4B9BF45568Q35246455-E2AE9915-40C1-4687-9C83-B2663F3FF5DAQ35657037-20F86241-789C-4E5A-A786-8AB9DE981BF4Q35671241-D7CE200B-FB61-47FB-9646-3A2FFEAEE679Q35863905-E2B2273F-5968-4214-A1E9-8D9294DAFAF1Q35879152-4ECE8C5B-3B72-4315-8E2D-B87407B96444Q36101603-A518615C-4BBD-408C-AB67-DEF11F9758DAQ36146313-07F9B98B-2FC2-4567-ACDB-6F450D568FFBQ36164026-E95CF29C-244E-47D5-9185-B36C5789B12BQ36224376-457FC4D9-7D12-4BAF-B977-F264514B3B10Q36258652-3401151D-3853-4F1D-ADF3-B20CD02DD2A8Q36305124-499F903C-A652-4173-8C9A-9C9669EDD5B9Q36335405-8996D53F-41BA-4688-A88E-CC332E510F91Q36390773-CE4AA745-9817-4B64-A252-E5EC7F9DD4E2Q36463149-8BF01FD1-7D8E-4BF5-A64F-8C8B7503A87CQ36527615-B29BC289-FA89-48FC-B811-F057A614D5C9Q36730771-8AD094D7-BBA1-4360-9F45-E2AC3A6D7A98Q37027776-032DBCA8-F3F5-4BD7-8C82-2A7FA968E650Q37043535-AAB88187-EE02-4350-B64B-2292C3BA549CQ37213485-D0DFB735-AF7E-460D-B9DD-DDD8F3AF6A5FQ37310531-CD77B2BB-77F7-4584-8434-CDDA74FF236FQ37378325-5D1CA9D2-DFB6-45FC-AD8B-A93D3D787ECDQ37661234-D1E81341-5EEB-407B-8CEB-289BD8CB58A8Q37672527-75159CCB-CF59-4D6E-9669-0A21B6731ADFQ37717892-CDF8459C-0CA9-467B-AFB0-8AAB1C1A92EDQ37787307-DEC82025-003D-4D5D-BA0E-E56E966549CDQ37833073-45B8E8F4-CBDF-400E-94D0-609DD9B8824DQ37848581-FFD963A5-F49E-48EC-9286-C6073CB832CCQ37932020-42C61D81-5EA2-4E91-B34C-5F78AAC065B1
P2860
Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Effect of a centralized clinic ...... es of anticoagulation therapy.
@en
Effect of a centralized clinic ...... es of anticoagulation therapy.
@nl
type
label
Effect of a centralized clinic ...... es of anticoagulation therapy.
@en
Effect of a centralized clinic ...... es of anticoagulation therapy.
@nl
prefLabel
Effect of a centralized clinic ...... es of anticoagulation therapy.
@en
Effect of a centralized clinic ...... es of anticoagulation therapy.
@nl
P2093
P356
P1433
P1476
Effect of a centralized clinic ...... es of anticoagulation therapy.
@en
P2093
Daniel M Witt
Donald J Tillman
Georgann Mazzoli
Melanie A Sadler
Roberta L Shanahan
P304
P356
10.1378/CHEST.127.5.1515
P407
P577
2005-05-01T00:00:00Z